[Clinical tests of a new corticoid for topical use: Nerisona]
- PMID: 795186
[Clinical tests of a new corticoid for topical use: Nerisona]
Abstract
Diflucortolone valerate 0.1% (Nerisona), a new topical corticoid, was clinically investigated in ointment form in 51 patients suffering from neither weeping nor very dry allergic and inflammatory skin diseases. The results obtained were good, improvement being observed in 92.1% of the treated cases. The cosmetic properties of the preparation were excellent. No local or systemic side effects were observed.
Similar articles
-
[Clinical tests with Nerisona cream (SH K 183 MB)].Z Hautkr. 1976;51 Suppl 1:56-9. Z Hautkr. 1976. PMID: 795191 Clinical Trial. German.
-
[Difluocortolone valerate in dermatology].Z Hautkr. 1976;51 Suppl 1:20-2. Z Hautkr. 1976. PMID: 795181 Clinical Trial. German.
-
[Results of a multi-center, international clinical trial of difluocortolone valerate (Nerisona)].Z Hautkr. 1976;51 Suppl 1:1-16. Z Hautkr. 1976. PMID: 795179 Clinical Trial. German.
-
[The combination of cyclosporin A and fluocortolone in the treatment of autoimmune diseases].Clin Ter. 1989 Oct 15;131(1):3-21. Clin Ter. 1989. PMID: 2531058 Review. Italian.
-
[Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age].Minerva Pediatr. 2009 Jun;61(3):323-31. Minerva Pediatr. 2009. PMID: 19461575 Review. Italian.